EUVIMEDEUVIMED entdecken
Crossref

Distributed Governance of Medical AI

W. Nicholson Price

SMU Science and Technology Law Review · 2022

DOI: 10.25172/smustlr.25.1.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SMU Science and Technology Law Review, 2022. Verfasst von W. Nicholson Price. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) has the potential to democratize expertise in medicine, bring expertise previously limited to specialists to a variety of health-care settings. But AI can easily falter, and making sure that AI works well across that variety of settings is a challenging task. Centralized governance, such as review by the Food and Drug Administration, can only do so much, since system performance will depend on the particular health-care setting and how the AI system is integrated into setting-specific clinical workflows. This Essay presents the need for distributed governance, where some oversight tasks are undertaken in localized settings. It points out the resource-based challenges of such governance and offers policy suggestions to ease the burden.

Zitieren

APA

Price, W. N. (2022). Distributed Governance of Medical AI. SMU Science and Technology Law Review. https://doi.org/10.25172/smustlr.25.1.2

Vancouver

Price WN. Distributed Governance of Medical AI. SMU Science and Technology Law Review. 2022. doi:10.25172/smustlr.25.1.2

BibTeX
@article{Price2022,
  author = {Price, W. Nicholson},
  title = {Distributed Governance of Medical AI},
  journal = {SMU Science and Technology Law Review},
  year = {2022},
  doi = {10.25172/smustlr.25.1.2}
}
Kostenlos starten →